Certara Announces Update of BaseCase Software

Latest release will provide biopharma and medical device companies greater commercial success.

Certara today announced the release of BaseCase software version 2021.06, which updates the company's value communication software platform to include new capabilities that can provide biopharmaceutical and medical device companies greater commercial success for new therapies and products.

The BaseCase software provides commercial, market access, and medical affairs teams a comprehensive, end-to-end environment to build state-of-the-art, interactive, data-driven mobile applications using multiple data sources, such as real-world data (RWD) and evidence (RWE). The software also enhances communications to demonstrate the value of therapies with payers, providers, and healthcare professionals.

For more information, click here.